Showing results (2881-2890 of 11,104) with videos related to
Sort By:
Pageof 1,111
Journal of the National Cancer Institute|December 10, 2024
The role of HPV16 in oral cavity and laryngeal cancers in the United StatesChristine M Kava, Anil K Chaturvedi, Virginia Senkomago, et al.Journal of the National Cancer Institute|November 20, 2024
The association of where patients with prostate cancer live and receive care on racial treatment inequitiesNoah Hammarlund, Sarah K Holt, Ruth Etzioni, et al.Journal of the National Cancer Institute|November 20, 2024
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabelingYibai Zhao, Roman Gulati, Zhenwei Yang, et al.Journal of the National Cancer Institute|November 20, 2024
Elevated risk of lung cancer among Asian American women who have never smoked: an emerging cancer disparityScarlett Lin Gomez, Mindy DeRouen, Moon S Chen, et al.Journal of the National Cancer Institute|November 12, 2024
Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort studyMaya Aboumrad, Corinne Joshu, Kala VisvanathanJournal of the National Cancer Institute|February 21, 2025
Colon, colorectal and all cancer incidence increase in the Young due to appendix reclassificationArchie Bleyer, Lynn A G Ries, Danielle B Cameron, et al.Journal of the National Cancer Institute|February 14, 2025
Development of a policy model for pediatric acute lymphoblastic leukemia to facilitate economic evaluationPetros Pechlivanoglou, Linda Luu, Qing Li, et al.Journal of the National Cancer Institute|October 29, 2024
Novel metabolomic predictors of incident colorectal cancer in men and womenJonathan M Downie, Amit D Joshi, Connor M Geraghty, et al.Journal of the National Cancer Institute|October 30, 2024
Contribution of health insurance to racial and ethnic disparities in advanced-stage diagnosis of 10 cancersParichoy Pal Choudhury, Helmneh M Sineshaw, Rachel A Freedman, et al.Journal of the National Cancer Institute|November 8, 2025
De-escalation trials do not always need to be non-inferiority- A case for superiority design de-escalation trials in oncologyBishal GyawaliPageof 1,111